Return on Equity (ROE) Summary

bioAffinity Technologies's ROE measures the return generated on shareholders' equity:

• Annual: -163.47%
• Quarterly: -61.47%
• TTM: -170.13%

What is Return on Equity (ROE)?

Return on Equity measures a company's ability to generate profits from its shareholders' equity. It indicates how effectively the management is using the company’s assets to create profits. A higher ROE generally reflects well on the company’s management and its ability to generate profits without needing as much capital.

Related Metrics

Other important metrics to assess bioAffinity Technologies's profitability include:

• ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
  • Annual: -124.25%
  • Quarterly: -53.14%
  • TTM: -220.34%
• ROA (Return on Assets) - measures the return generated on the company's assets:
  • Annual: -96.54%
  • Quarterly: -31.70%
  • TTM: -131.24%
• Profit Margin - indicates the profitability of the company relative to its revenue:
  • Annual: -313.41%
  • Quarterly: -88.01%
  • TTM: -119.41%

These metrics provide insights into bioAffinity Technologies's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

bioAffinity Technologies Historical ROE

Historical ROIC

Historical ROA